
Boehringer Ingelheim, IBM to study blockchain in clinical trials
At the ongoing HIMSS conference in Orlando, Florida, the companies' Canadian divisions said their partnership would mark the technology's first use in clinical trials in Canada.
At the ongoing HIMSS conference in Orlando, Florida, the companies' Canadian divisions said their partnership would mark the technology's first use in clinical trials in Canada.
As part of the acquisition, the health system is bringing on Lumedic's employees and IP assets to form a new company that will work to sign up partnerships with other healthcare stakeholders like payer organizations.
This on-demand webinar will offer insights and share tips on helping practices run more efficiently.
Experts weighed in on how the move could change the way drugmakers raise money for development programs. But as digital securities as a financial instrument gain traction, they could carry potential risks too.
The drugmaker called its offering, scheduled for next month and meant to finance development of the drug AGEN2034, a first in healthcare and said it expects others to use the same means to raise capital.
Even as the hype around cryptocurrencies like Bitcoin have died down, major players are investing in applications to bring blockchain to healthcare.
A roundup of some of the biggest trends and events in pharmaceuticals, biotechnology and diagnostics in 2018, including regulatory approvals, international trends, national policy and more.
A new report from Relatient, A Data-Driven Guide to Patient Access Succes, highlights how focusing on data accuracy and relevance can enhance the performance of healthcare practices.
Change Healthcare, which is majority-owned by McKesson, will integrate PokitDok's APIs into its existing Intelligent Healthcare Network, which relies on blockchain for processing transactions.
Although blockchain faces regulatory hurdles and skepticism, its potential as a shared, yet secure ledger system to improve the pharmaceutical supply chain integrity and clinical trials is making it attractive for experimentation and investment by drugmakers.
Keeping health plan provider directories current is a major administrative and cost burden for the industry, with an estimated $2.1 billion spent annually across the healthcare system to acquire and maintain provider data.
Dubbed PatientSphere, Open Health Network's platform ingests patient data from sources like EHR records, mobile health applications, wearable devices and programs like Apple HealthKit into one dashboard.
In a phone interview, Jamie Thomas, general manager of strategy and development for IBM Systems, advised healthcare IT executives to have a data management strategy and to keep security top of mind.
Health information exchanges are now focused on creating nothing less than the Patient-Centered Data Home accessible nationally. However, before doing so they must ask themselves some hard questions.
In a Q&A, Optum Technology's Kerrie Holley discuses the potential of big data in healthcare, some of the barriers to adoption what can be done to win back the trust of patients.
The company plans to use blockchain and other technologies to develop the genomic data marketplace, under a partnership with Veritas Genetics.
The company's life sciences track-and-trace network reaches drugmakers, pharmacies and others, with a customer base of more than 930 companies.